These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 19038694)
1. Holidays, triggers, and willpower--is there a role for medications? A commentary on "The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients". Rosenbloom DL J Subst Abuse Treat; 2009 Jan; 36(1):7. PubMed ID: 19038694 [No Abstract] [Full Text] [Related]
2. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients. Lapham S; Forman R; Alexander M; Illeperuma A; Bohn MJ J Subst Abuse Treat; 2009 Jan; 36(1):1-6. PubMed ID: 18775624 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment. O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686 [TBL] [Abstract][Full Text] [Related]
5. Intramuscular extended-release naltrexone: current evidence. Gastfriend DR Ann N Y Acad Sci; 2011 Jan; 1216():144-66. PubMed ID: 21272018 [TBL] [Abstract][Full Text] [Related]
6. Long-acting injectable naltrexone for the treatment of alcohol dependence. Mannelli P; Peindl K; Masand PS; Patkar AA Expert Rev Neurother; 2007 Oct; 7(10):1265-77. PubMed ID: 17939765 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of naltrexone in the treatment of alcohol dependence: oral versus injectable delivery. Roozen HG; de Waart R; van den Brink W Eur Addict Res; 2007; 13(4):201-6. PubMed ID: 17851241 [TBL] [Abstract][Full Text] [Related]
13. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism". Krystal JH; Gueorguieva R; Cramer J; Collins J; Rosenheck R; Alcohol Clin Exp Res; 2008 Jan; 32(1):85-91. PubMed ID: 18070245 [TBL] [Abstract][Full Text] [Related]
14. Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates. Weinrieb RM; Van Horn DH; McLellan AT; Volpicelli JR; Calarco JS; Lucey MR J Addict Dis; 2001; 20(2):105-19. PubMed ID: 11318394 [TBL] [Abstract][Full Text] [Related]
15. The use of depot naltrexone under legal coercion: the case for caution. Hall W; Capps B; Carter A Addiction; 2008 Dec; 103(12):1922-4. PubMed ID: 19469728 [No Abstract] [Full Text] [Related]
16. Strategies to maximize the efficacy of naltrexone for alcohol dependence. O'Malley SS NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772 [No Abstract] [Full Text] [Related]
17. Lack of information in naltrexone study. Rastegar DA Arch Gen Psychiatry; 2007 Jul; 64(7):865; author reply 865. PubMed ID: 17606820 [No Abstract] [Full Text] [Related]
18. Behavioral consequences of repeated nicotine during adolescence in alcohol-preferring AA and alcohol-avoiding ANA rats. Kemppainen H; Hyytiä P; Kiianmaa K Alcohol Clin Exp Res; 2009 Feb; 33(2):340-9. PubMed ID: 19032573 [TBL] [Abstract][Full Text] [Related]
19. Extended-release intramuscular naltrexone: a viewpoint by Falk Kiefer. Kiefer F Drugs; 2006; 66(13):1752-3. PubMed ID: 16978039 [No Abstract] [Full Text] [Related]
20. Targeted naltrexone treatment moderates the relations between mood and drinking behavior among problem drinkers. Kranzler HR; Armeli S; Feinn R; Tennen H J Consult Clin Psychol; 2004 Apr; 72(2):317-27. PubMed ID: 15065964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]